Clinical studies show the positive effects of Reconval K1 on skin and cancer therapy

Available in your pharmacy for CHF 24.90!

Reconval K1

Side effects of EGFR-inhibitors on the epidermis

About 45-100% of patients suffer from toxic-epidermal side effects. The most common reactions include papulopustular rash, dry and itchy skin, inflammation around the nails, loss of hair but increased growth of eyelashes and facial hair.

Acne-like rash is present in 80% of all patients and mainly affects the face, torso and head. A successful therapeutic outcome of the cancer treatment often correlates with the application of Reconval K1.


Cancers, causing skin changes

  • Cervical cancer
  • Pancreatic cancer
  • Metastatic breast cancer
  • Metastatic kidney cancer
  • Hepatocellular carcinoma
  • Non-small cell lung cancer (NSCLC)
  • Advanced renal cell carcinoma
  • Metastic colorectal cancer (mCRC)
  • Squamous cell carcinoma of the head and neck (SCCHN)

Reconval B6

Epidermal side effects of VGFR inhibitors and radiotherapy

Side effects while cancer treatment and radiotherapy can cause painful, diffuse and symmetric erythema or oedema of the hands and feet.

The skin on the palms and soles painfully peels off. Reconval B6 prevents this undesired effect and alleviates existing inflammations.


Cancers that cause skin changes

  • Cystic therapies:
    • Liver cancer
    • Colon cancer
    • Kidney cancer
    • Breast cancer
    • Ovarian cancer
  • Chronic myeloid leukemia (hand-foot syndrome)
  • Radiation dermatitis (radiotherapy)